Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Inter-laboratory evaluation of instrument platforms and experimental workflows for quantitative accuracy and reproducibility assessment

  • Percy, Andrew J.
  • Tamura-Wells, Jessica
  • Albar, Juan Pablo
  • Aloria, Kerman
  • Amirkhani, Ardeshir
  • Araújo, Gabriel D.T.
  • Arizmendi, Jesús M.
  • Blanco García, Francisco J
  • Canals, Francesc
  • Cho, Jin-Young
  • Colomé-Calls, Núria
  • Corrales, Fernando J.
  • Domont, Gilberto
  • Espadas, Guadalupe
  • Fernández-Puente, Patricia
  • Gil, Concha
  • Haynes, Paul A.
  • Hernáez, María Luisa
  • Kim, Jin Young
  • Kopylov, Arthur T.
  • Marcilla, Miguel
  • McKay, Mathew J.
  • Mirzaei, Mehdi
  • Molloy, Mark P.
  • Ohlund, Leanne B.
  • Paik, Young-Ki
  • Paradela, Alberto
  • Raftery, Mark
  • Sabidó, Eduard
  • Sleno, Lekha
  • Wilffert, Daniel
  • Wolters, Justina C.
  • Yoo, Jong Shin
  • Zgoda, Victor G.
  • Parker, Carol E.
  • Borchers, Christoph H.
[Abstract] The reproducibility of plasma protein quantitation between laboratories and between instrument types was examined in a large-scale international study involving 16 laboratories and 19 LC-MS/MS platforms, using two kits designed to evaluate instrument performance and one kit designed to evaluate the entire bottom-up workflow. There was little effect of instrument type on the quality of the results, demonstrating the robustness of LC/MRM-MS with isotopically labeled standards. Technician skill was a factor, as errors in sample preparation and sub-optimal LC-MS performance were evident. This highlights the importance of proper training and routine quality control before quantitation is done on patient samples., The UVic-Genome BC Proteomics Centre would like to thank Genome Canada and Genome British Columbia for STIC funding and support, as well as Western Economic Diversification of Canada for instrumentation support. All laboratories from Spain are members of ProteoRed (Plataforma de Recursos Biomoleculares y Bioinformáticos) and are supported by grant PT13/0001 funded by Instituto de Salud Carlos III (ISCIII) and the European Regional Development Fund (FEDER). FC wishes to acknowledge support from Grant PRB2 (IPT13/0001 - ISCIII-SGEFI/FEDER). GD wishes to acknowledge support from grants FAPERJ E26-110.138/2013, FAPERJ E-26/111.697/2013, and FAPERJ E-26/0010.1582/2014. AK and VZ state that the Russian portion of the work was done in the framework of the State Academies Fundamental Research Program (2013-2020). Reynaldo Interior (Hospital for Sick Children; Toronto, ON, Canada), Jay Gambee (AAA Service Laboratory; Damascus, OR, USA), and David Chen (University of British Columbia; Vancouver, BC, Canada) are recognized for characterizing the 43 SIS peptides. PAH wishes to thank Ardeshir Amirkhani of the Australian Proteome Analysis Facility, Macquarie University, Sydney, Australia for assistance with sample preparation and data analysis.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Analysis of Autoantibody Profiles in Osteoarthritis Using Comprehensive Protein Array Concepts

  • Henjes, Frauke
  • Lourido, Lucía
  • Ruiz-Romero, Cristina
  • Fernández-Tajes, Juan
  • Schwenk, Jochen M.
  • González-González, María
  • Blanco García, Francisco J
  • Nilsson, Peter
  • Fuentes, Manuel
[Abstract] Osteoarthritis (OA) is the most common rheumatic disease and one of the most disabling pathologies worldwide. To date, the diagnostic methods of OA are very limited, and there are no available medications capable of halting its characteristic cartilage degeneration. Therefore, there is a significant interest in new biomarkers useful for the early diagnosis, prognosis, and therapeutic monitoring. In the recent years, protein microarrays have emerged as a powerful proteomic tool to search for new biomarkers. In this study, we have used two concepts for generating protein arrays, antigen microarrays, and NAPPA (nucleic acid programmable protein arrays), to characterize differential autoantibody profiles in a set of 62 samples from OA, rheumatoid arthritis (RA), and healthy controls. An untargeted screen was performed on 3840 protein fragments spotted on planar antigen arrays, and 373 antigens were selected for validation on bead-based arrays. In the NAPPA approach, a targeted screening was performed on 80 preselected proteins. The autoantibody targeting CHST14 was validated by ELISA in the same set of patients. Altogether, nine and seven disease related autoantibody target candidates were identified, and this work demonstrates a combination of these two array concepts for biomarker discovery and their usefulness for characterizing disease-specific autoantibody profiles., We gratefully acknowledge financial support from Euro-TEAM (EU FP7), Knut and Alice Wallenberg Foundation, SciLifeLab Stockholm, the Carlos III Health Institute of Spain (FIS PI11/02114, PI11/02397, PI12/00329; CIBER-CB06/01/0040; RETIC-RIER-RD12/0009/0018), FEDER (European Community), Xunta de Galicia (Red Gallega REDICENT), and Junta Castilla-León SA198A12-2. The Proteomics Unit at CIC belongs to ProteoRed, PRB2-ISCIII, supported by grant PT13/0001.